The indications for aspirin enteric tablets are: reduction of the risk of morbidity in patients with suspected acute myocardial infarction, prevention of recurrence of myocardial infarction, secondary prevention of stroke, reduction of the risk of transient ischemic attack and its secondary stroke, reduction of the risk of morbidity in patients with stable and unstable angina, post-operative arterial surgery and interventional procedures, prevention of deep vein thrombosis and pulmonary embolism after major surgery, reduction of cardiovascular risk factors risk of acute myocardial infarction episodes in patients. Aspirin Enteric Solution 1 tablet is 100mg and is administered orally, with appropriate amount of water before meals, to reduce the risk of acute myocardial infarction in patients with suspected myocardial infarction. 300mg chewable is the recommended first dose, followed by 100mg orally daily. Adverse reactions: Adverse reactions to aspirin enteric soluble tablets include gastrointestinal discomfort, bleeding, hemolysis and hemolytic anemia in patients with severe glucose-6-phosphatase deficiency, renal injury and acute renal failure, and allergic reactions. Contraindications: It is contraindicated in patients with hypersensitivity to aspirin or other salicylic acids and any component of the drug. Active peptic ulcer, bleeding constitution, severe heart, liver and kidney failure, as well as the second trimester of pregnancy are prohibited.